Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TILDRAKIZUMAB vs TIMOLOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TILDRAKIZUMAB vs TIMOLOL: Safety Overview

Metric TILDRAKIZUMAB TIMOLOL
Total FAERS Reports 869 7,450
Deaths Reported 89 66
Death Rate 10.2% 0.9%
Hospitalizations 389 450
Average Patient Age 57.9 yrs 67.1 yrs
% Female Patients 42.5% 61.9%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Sun Pharmaceutical Industries, Inc. Bausch & Lomb Incorporated
Route SUBCUTANEOUS OPHTHALMIC
Marketing Status N/A Discontinued